Low Alcohol and Cigarette Use Is Associated to the Risk of Developing Chronic Pancreatitis

Pancreas. 2017 Feb;46(2):225-229. doi: 10.1097/MPA.0000000000000737.

Abstract

Objectives: The aim of this study was to investigate the contribution of smoking and alcohol intake and pancreas divisum on the risk of developing chronic pancreatitis (CP).

Methods: Consecutive patients with CP who underwent secretin-enhanced magnetic resonance cholangiopancreatography were compared with consecutive patients without pancreatic disease who underwent secretin-enhanced magnetic resonance cholangiopancreatography for irritable bowel syndrome.

Results: We enrolled 145 consecutive CP patients and 103 irritable bowel syndrome patients from 2010 to 2014. In a univariate analysis, statistically significant differences in sex, mean age, and the duration and amount of cigarette and alcohol use were found. Per a receiver operating characteristic curve analysis, thresholds for cigarette and alcohol consumption were, respectively, 5.5 cigarettes and 13.5 g daily. In a multivariate analysis, independent risk factors for CP were male sex (odds ratio [OR], 2.05), smoking more than 5.5 cigarettes per day (OR, 2.72), and drinking more than 13.5 g/d (OR, 6.35).

Conclusions: In an Italian population, we confirmed smoking and alcohol as cofactors in the development of CP. This study shows that alcohol intake and smoking habits are 2 of the most important risk factors for the development of CP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcohol Drinking / adverse effects*
  • Cholangiopancreatography, Magnetic Resonance
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Mutation
  • Pancreas / abnormalities*
  • Pancreatic Diseases / complications*
  • Pancreatitis, Chronic / diagnostic imaging
  • Pancreatitis, Chronic / etiology*
  • Pancreatitis, Chronic / genetics
  • Risk Factors
  • Smoking / adverse effects*

Substances

  • Cystic Fibrosis Transmembrane Conductance Regulator